Last reviewed · How we verify
NCT06062511
Poplar-type Propolis Dry Extract ESIT12 : Nutrikinetic and Bioavailability Studies
NA trial testing ESIT12 D in Nutrition, Healthy in 10 participants. Completed in 10 October 2023.
10 October 2023
Quick facts
| Lead sponsor | Fytexia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 10 |
| Start date | 22 July 2023 |
| Primary completion | 10 October 2023 |
| Estimated completion | 10 October 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- ESIT12 D
- ESIT12 4D
- Placebo
Conditions studied
- Nutrition, Healthy — all drugs for Nutrition, Healthy →
Sponsor
Fytexia
Who can join
Adults 25 to 69, any sex, with Nutrition, Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate phenolic compounds from ESIT12, a poplar-type propolis ingredient, bioavailability and nutrikinetics by measuring urinary excretion and metabolic profile over 48h by means of high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS). The study follows a cross-over, double-blind, randomized and placebo control design on 10 healthy subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06062511
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nutrition, Healthy
Currently open trials in the same condition.
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06897982 — Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center · NA · recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
- NCT07054294 — Total Energy Expenditure Across the Life Course in Low-and Middle-Income Countries -- Chinese Children · recruiting
- NCT07056504 — Technologies and Systems for Assessing Human Energy Metabolism and Nutritional Rehabilitation · recruiting
Other Fytexia trials
Trials by the same sponsor.
- NCT06949592 — Oral Bioavailability of the Phenolic Compounds in a Melissa Supplement · NA · completed
- NCT05926947 — OXXYNEA® GS: Study for Glycaemia Management · NA · active not recruiting
- NCT05598749 — Poplar-type Propolis Dry Extract ESIT12 : Immunomodulation Efficacy Study · NA · completed
- NCT04914416 — Evaluation of OxxyneaGS in Acute Glycemic Regulation on Light Hyperglycemic Subjects · NA · completed
- NCT04765189 — Evaluation of Mangoselect® in Improvement of Exercise/Activity-induced Knee Joint Discomfort in Subjects Suffering From · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06062511 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fytexia
- Last refreshed: 8 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06062511.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing